Delivery Order SPE2DB20D3505-SPE2DB25FU8D9

Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,852.98, is a Delivery Order for the supply of 4568367035 - DEXTROAMP-AMPHET ER 20 MG CAP 100S. It is a Firm Fixed Price contract with a period of performance through May 28, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,609.51 firm fixed-price delivery order is for the supply of 4567528198 - DEXTROAMP-AMPHET ER 10 MG CAP 100S. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order worth $2,360.49 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, with a performance period through May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,321.11 delivery order contract is for the supply of 4562225300 DEXTROAMP-AMPHET ER 30 MG CAP 100S, a pharmaceutical product, with a completion date of September 20, 2023. The contract has a firm fixed price pricing type and was not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.95 firm-fixed-price delivery order is for the supply of DEXTROAMP-AMPHET ER 25 MG CAP 100S, a prescription medication, with a period of performance through June 9, 2025. The contract is not set aside and allows for open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $1,191.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1202|SPE2DB25FUYU0) for the supply of 4568040534 - DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price arrangement. This contract is not associated with a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $1,401.52 and a completion date of May 29, 2025. The award is for the supply of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, and is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,112.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for DEXTROAMP-AMPHET ER 30 MG CAP 100S, with an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract,...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,232.45 with a Firm Fixed Price pricing type. It is for the supply of 4568567876 DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract has an Ultimate Completion Date of June 17, 2025 and was awarded on June 16, 2025. The contract is not set aside and is...
This federal contract award, valued at $1,509.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, with a performance period through April 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FU8D9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,152.99, is a delivery order for 4568569097 - DEXTROAMP-AMPHET ER 20 MG CAP 100S. The contract is a firm fixed-price, non-set-aside award with a completion date of June 17, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/15/25, 9:57 AM